Inogen Inc
Last updated September 27, 2026
Organization details
- Legal name
- Inogen Inc
- Ownership
- Public
- Status
- Active
- SIC code
- 3842 — Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Beverly
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- INGN
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001294133
Board of directors
-
Elizabeth Mora · DirectorSince 2023
-
Glenn S. Boehnlein · DirectorSince 2023
-
Heather D. Rider · DirectorSince 2023
-
Kevin M. King · DirectorSince 2023
-
Kevin Raymond Merrill Smith · Director · CEO and PresidentSince 2023
-
Mary Kay Ladone · DirectorSince 2023
-
Mira Kirti Sahney · DirectorSince 2025
-
Nabil Shabshab · Director · CEO and PresidentSince 2023
-
Thomas A. West · DirectorSince 2023
-
Vafa Jamali · DirectorSince 2026
Chief executives
Kevin Raymond Merrill Smith
· CEO and President
Dates unknown
Nabil Shabshab
· CEO and President
Dates unknown
Director election results
Annual meeting of June 5, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
72.7%
-
94.8%
Board connections
4 of this board's directors also sit on 11 other boards.
- via Glenn S. Boehnlein
- via Mary Kay Ladone
- via Thomas A. West
- via Glenn S. Boehnlein
- via Mary Kay Ladone
- via Elizabeth Mora
- via Elizabeth Mora
- via Mary Kay Ladone
- via Elizabeth Mora
- via Thomas A. West
- via Thomas A. West
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $142,474
- 2 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 1, 2026 | Kevin Raymond Merrill Smith Director, Officer (CEO and President) | Grant or award | +1,500 | $5.33 | $7,995 |
| Sep 1, 2026 | Smith Kevin P. Officer (EVP, Bus Dev, GC & Sec) | Grant or award | +1,500 | $5.33 | $7,995 |
| Sep 1, 2026 | Wright Mary E Officer (VP, Chief Accounting Officer) | Grant or award | +1,500 | $5.33 | $7,995 |
| Sep 1, 2026 | Smith Kevin P. Officer (EVP, Bus Dev, GC & Sec) | Option exercise | +18,136 | — | — |
| Sep 1, 2026 | Smith Kevin P. Officer (EVP, Bus Dev, GC & Sec) | Shares withheld for tax | −8,671 | $5.33 | $46,216 |
| Jul 1, 2026 | Yi Boyer Jennifer M Officer (EVP Entrprs Enblmnt, Ch HR Off) | Open-market sale | −10,938 | $6.60 | $72,146 |
| Jun 5, 2026 | Mira Kirti Sahney Director | Grant or award | +28,081 | — | — |
| Jun 5, 2026 | Vafa Jamali Director | Grant or award | +28,081 | — | — |
| Jun 5, 2026 | Glenn S. Boehnlein Director | Grant or award | +28,081 | — | — |
| Jun 5, 2026 | Heather D. Rider Director | Grant or award | +28,081 | — | — |
| Jun 5, 2026 | Elizabeth Mora Director | Grant or award | +28,081 | — | — |
| Jun 5, 2026 | Mary Kay Ladone Director | Grant or award | +28,081 | — | — |
| Jun 5, 2026 | Kevin M. King Director | Grant or award | +28,081 | — | — |
| May 29, 2026 | Yi Boyer Jennifer M Officer (EVP Entrprs Enblmnt, Ch HR Off) | Open-market sale | −10,770 | $6.53 | $70,328 |
| Mar 1, 2026 | Wright Mary E Officer (VP, Chief Accounting Officer) | Grant or award | +1,500 | $6.10 | $9,150 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.